Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

Ani Pharmaceuticals (ANIP) Short-Term Debt issuances: 2012-2021

  • Ani Pharmaceuticals' Short-Term Debt issuances rose 1846.88% to $262.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $286.0 million, marking a year-over-year increase of 1044.13%. This contributed to the annual value of $286.0 million for FY2021, which is N/A change from last year.
  • Ani Pharmaceuticals' Short-Term Debt issuances amounted to $262.0 million in Q4 2021, which was up 991.80% from $24.0 million recorded in Q2 2021.
  • In the past 5 years, Ani Pharmaceuticals' Short-Term Debt issuances registered a high of $262.0 million during Q4 2021, and its lowest value of -$15.0 million during Q4 2020.
  • In the last 2 years, Ani Pharmaceuticals' Short-Term Debt issuances had a median value of $19.5 million in 2020 and averaged $71.5 million.
  • Data for Ani Pharmaceuticals' Short-Term Debt issuances shows a peak YoY surged of 1,846.88% (in 2021) over the last 5 years.
  • Quarterly analysis of 3 years shows Ani Pharmaceuticals' Short-Term Debt issuances stood at -$5.0 million in 2017, then reached -$15.0 million in 2020, then skyrocketed by 1,846.88% to $262.0 million in 2021.
  • Its last three reported values are $262.0 million in Q4 2021, $24.0 million for Q2 2021, and -$15.0 million during Q4 2020.